References
Aguilar M-I and DH Small (2005) Surface plasmon resonance for the analysis of β-amyloid interactions and fibril formation in Alzheimer’s disease research.Neurotoxicity Res. 7, 17–27.
Barral JM, SA Broadley, G Schaffar and FU Hartl (2004) Roles of molecular chaperones in protein misfolding diseases.Semin. Cell. Dev. Biol. 15, 17–29.
Boyle K, MF Azari, C Profyris and S Petratos (2005) Molecular mechanisms in Schwann cell survival and death during peripheral nerve development, injury and disease.Neurotoxicity Res. 7, 151–167.
Broe M, CE Shepherd, DMA Mann, EA Milward, W-P Gai, E Thiel and GM Halliday (2005) Insoluble α-synuclein in Alzheimer’s disease without Lewy body formationNeurotoxicity Res. 7, 69–76.
DittmanJ, SJ Fung, JC Vickers, MI Chuah, RS Chung and AD West (2005) Metallothionein biology in the ageing and neurodegenerative brin.Neurotoxicity Res. 7, 87–93.
Iwai A, E Maslia, M Yoshimoto, N Ge, L Flanagan, HA de Silva, A Kittel and T Saitoh (1995) The precursor protein of non-A beta component of Alzheimer’s disease amyloid is a presynaptic protein of the central nervous system.Neuron 14, 467–475.
Feng S-Q, X-H Kong, S-F Guo, P Wang, LI Li, J-H Zhong andX-F Zhou (2005) Treatment of spinal cord injury with co-grafts of genetically modified Schwann cells and fetal spinal cord cell suspension in the rat.Neurotoxicity Res. 7, 169–176.
Gregory GCand GM Halliday (2005) What is the dominant Aβ pecies in human brain tissue? A review.Neurotoxicity Res. 7, 29–42.
Guilleman GJ, SJ Kerr and BJ Brew (2005) Involvement of quinolinic acid in AIDS dementia complex.Neurotoxicity Res. 7, 103–124.
Karnezis T, W Mandemakers, JL McQualter, B Zheng, PP Ho, KA Jordan, BM Murray, B Barres, M Tessier-Lavigne and CCBernard (2004) The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination.Nat. Neurosci. 7, 736–744.
Mattson MP (1997) Neuroprotective signal transduction: relevance to stroke.Neurosci. Biobehav. Rev. 21, 193–206.
Poutney DL, NH Voelcker and WP Gai (2005a) Annular alphasynuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis.Neurotoxicity Res. 7, 59–67.
Poutney DL, TM Treweek, T Chataway, Y Huang, F Chegini, PC Blumbergs, MJ Raftery and WP Gai (2005b) αB-Crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy.Neurotoxicity Res. 7, 77–85.
Small DH, SS Mok and J Bornstein (2001) Alzheimer’s disease and A toxicity: from top to bottom.Nat. Rev. Neurobiol. 2, 595–598.
Tsai VW-W, HL Scott, RJ Lewis and PR Dodd (2005) The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer’s disease.Neurotoxicity Res. 7, 125–141.
Walsh DM and DH Selkoe (2004) Deciphering the molecular basis of memory failure in Alzheimer’s disease.Neuron 44, 181–193.
Walsh R, E Storey, D Stefani, L Kelly and V Turnbull (2005) The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review.Neurotoxicity Res. 7, 43–57.
Webster J, C Urban, K Berbaum, C Loske, A Alpar, U Gärtner, S Garcia de Arriba, T Arendt and G Munch (2005) The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxalNeurotoxicity Res. 7, 95–101.
Woodhouse A, AK West, JA Chuckowree, JC Vickers and TC Dickson (2005) Does β-amyloid plaque formation cause structural injury to neuronal processes?Neurotoxicity Res. 7, 5–15.
Zagami CJ, RD O’Shea, CL Lau, SS Cheema and PM Beart (2005) Regulation of glutamate transporters in astrocytes: evidence for a relationship between transporter expression and astrocytic phenotype.Neurotoxicity Res. 7, 143–149.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Small, D.H. Biochemical, cellular and behavioural aspects of neurodegeneration: The view from down under. neurotox res 7, 1–3 (2005). https://doi.org/10.1007/BF03033771
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF03033771